On November 5, James Hardie Industries PLC rose 7.26% in Regular Trading, trading at $29.195/share, with turnover of $147 million.
The move coincided with investor focus on the company’s upcoming quarterly results later that day, with consensus expectations calling for revenue of $1.483 billion, up 16.48% year over year, EBIT of $316 million, up 33.94%, and adjusted EPS of $0.39, up 61.03%.
Supporting context has been constructive: the prior quarter beat expectations with adjusted EPS of $0.36 on sales of $1.475 billion, and analysts turned more positive afterward. Recent strategic updates also highlighted a $23 billion North American material-conversion opportunity, while the company has been sharpening portfolio focus through the sale of its Fermacell business for 840 million euros and authorization of a $250 million buyback.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments